“I just don't like
standing still.”
KATJA BULLER, M.D.
Senior Director, Public Affairs
Using her ability to communicate complex science in simple terms, Katja Buller has built upon her career as a physician to help people understand how our breakthrough therapies can impact people's lives.
“At Biogen Idec, we can
be creative and feel
free to take risks.”
SHA MI (MISHA), PhD.
Principal Investigator, Neurobiology
Misha discovered a molecule called LINGO which, when blocked, facilitates the regeneration of nerves. She is developing an anti-LINGO antibody that may revolutionize central nervous system treatment.
“We have a passion
for our patients that
is unparalelled.”
RICK DAY.
Program Manager, Patient Services
Rick Day and Katie Preston are part of our 300 person team in Patient Services that work to help patients live better lives with their diseases and ensure physicians have all the medical information on our products.
“We take innovation
from the cool to the
actual, practical...to reality.”
JOYDEEP GANGULY
Director, Global GMP Sourcing and Procurement
Joydeep Ganguly comes from a family of doctors. He is continuing his family tradition of helping patients by creating groundbreaking mathematical models that help Biogen Idec discover new medicines.
Vår visjon:
“Through excellence in all that we do, Biogen Idec will become the most effective and most admired company in the biopharmaceutical industry, providing meaningful benefits for patient and exceptional value for shareholders”.
Biogen Idec er et globalt, børsnotert bioteknologisk selskap med hovedkontor i USA. Vi har ca. 5.000 ansatte verden over. Det norske kontoret ligger i Oslo og her er vi 12 ansatte.
I Norge markedsfører vi tre produkter mot MS.
